Home/Filings/4/0001753926-26-000169
4//SEC Filing

BENSOUSSAN TORRES ROBERT 4

Accession 0001753926-26-000169

CIK 0000822663other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 4:20 PM ET

Size

38.0 KB

Accession

0001753926-26-000169

Research Summary

AI-generated summary of this filing

Updated

Interparfums (IPAR) Director Robert Bensoussan Exercises 1,500 Options

What Happened

  • Robert Bensoussan, a director of Interparfums Inc. (IPAR), exercised stock option rights on 2026-01-22 to acquire 1,500 shares at an exercise price of $62.18 per share, a transaction valued at $93,270.
  • The filing also reports four separate derivative disposals of 375 shares each at $0.00 (each reported as an M-code derivative transaction on the same date). These disposals are listed at $0 in the filing.

Key Details

  • Transaction date: 2026-01-22 (Form 4 filed 2026-01-23; filing appears timely).
  • Acquired: 1,500 shares via option exercise at $62.18 — total cash paid $93,270.
  • Disposed: 4 × 375 shares at $0.00 (derivative entries) reported on same date.
  • Shares owned after transaction: not specified in the provided data.
  • Transaction code: M = exercise/conversion of derivative. Disposals reported at $0 often reflect shares withheld to satisfy tax withholding or similar mechanics (see Context).
  • No indication in the provided data of a 10b5-1 plan or other special plan; no late filing flag noted.

Context

  • For option exercises it’s common for some shares to be surrendered or withheld to cover exercise costs or tax withholding; when those withheld/surrendered shares are reported at $0, they typically reflect that mechanic rather than an open‑market sale.
  • An exercised option is not the same as an open‑market purchase or sale: it reflects conversion of a derivative right into shares. Purchases (net cash outflow to acquire shares) are often viewed as a more direct bullish signal than routine tax withholding or option exercises.
  • This summary is factual only; the filing does not state motivations behind the transactions.

Insider Transaction Report

Form 4
Period: 2026-01-22
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-22$62.18/sh+1,500$93,27012,500 total
  • Exercise/Conversion

    Option-right to buy

    2026-01-223750 total
    Exercise: $62.18From: 2022-02-01Exp: 2026-01-31Common Stock (375 underlying)
  • Exercise/Conversion

    Option-right to buy

    2026-01-223750 total
    Exercise: $62.18From: 2023-02-01Exp: 2026-01-31Common Stock (375 underlying)
  • Exercise/Conversion

    Option-right to buy

    2026-01-223750 total
    Exercise: $62.18From: 2024-02-01Exp: 2026-01-31Common Stock (375 underlying)
  • Exercise/Conversion

    Option-right to buy

    2026-01-223750 total
    Exercise: $62.18From: 2025-02-01Exp: 2026-01-31Common Stock (375 underlying)
Holdings
  • Common Stock

    11,000
  • Option-right to buy

    Exercise: $97.84From: 2023-12-31Exp: 2028-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $97.84From: 2024-12-31Exp: 2028-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $97.84From: 2025-12-31Exp: 2028-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $97.84From: 2026-12-31Exp: 2028-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $97.84From: 2027-12-31Exp: 2028-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $147.71From: 2024-12-29Exp: 2029-12-28Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $147.71From: 2025-12-29Exp: 2029-12-28Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $147.71From: 2026-12-29Exp: 2029-12-28Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $147.71From: 2027-12-29Exp: 2029-12-28Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $147.71From: 2028-12-29Exp: 2029-12-28Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $130.60From: 2025-12-31Exp: 2030-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $130.60From: 2026-12-31Exp: 2030-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $130.60From: 2027-12-31Exp: 2030-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $130.60From: 2028-12-31Exp: 2030-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $130.60From: 2029-12-31Exp: 2030-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $84.64From: 2026-12-31Exp: 2031-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $84.64From: 2027-12-31Exp: 2031-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $84.64From: 2028-12-31Exp: 2031-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $84.64From: 2029-12-31Exp: 2031-12-30Common Stock (300 underlying)
    300
  • Option-right to buy

    Exercise: $84.64From: 2030-12-31Exp: 2031-12-30Common Stock (300 underlying)
    300
Signature
/s/ Robert Bensoussan-Torres by Joseph A. Caccamo as attorney-in-fact|2026-01-23

Issuer

INTERPARFUMS INC

CIK 0000822663

Entity typeother

Related Parties

1
  • filerCIK 0001211775

Filing Metadata

Form type
4
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 4:20 PM ET
Size
38.0 KB